Page last updated: 2024-11-03

procainamide and Sclerosis, Systemic

procainamide has been researched along with Sclerosis, Systemic in 5 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobs, RP1
Kameda, H1
Mimori, T1
Kaburaki, J1
Fujii, T1
Takahashi, T1
Akaishi, M1
Ikeda, Y1
Tan, EM1
Chan, EK1
Sullivan, KF1
Rubin, RL1
Stevens, MB1
Tuffanelli, DL1

Reviews

3 reviews available for procainamide and Sclerosis, Systemic

ArticleYear
Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.
    Clinical immunology and immunopathology, 1988, Volume: 47, Issue:2

    Topics: Antibodies, Antinuclear; Autoantigens; Autoimmune Diseases; Cell Nucleus; Connective Tissue Diseases

1988
Connective tissue disease in the elderly.
    Clinics in rheumatic diseases, 1986, Volume: 12, Issue:1

    Topics: Aged; Connective Tissue Diseases; Dermatomyositis; Female; Giant Cell Arteritis; Humans; Hydralazine

1986
A primer of collagen disease.
    Minnesota medicine, 1974, Volume: 57, Issue:10

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antibodies; Central Nervous System Disease

1974

Other Studies

2 other studies available for procainamide and Sclerosis, Systemic

ArticleYear
Drug-induced rheumatic diseases.
    Comprehensive therapy, 1984, Volume: 10, Issue:8

    Topics: Adrenal Cortex Hormones; Anticonvulsants; Antineoplastic Agents; Diuretics; Gout; Heparin; Humans; H

1984
Systemic sclerosis complicated by procainamide-induced lupus and antiphospholipid syndrome.
    British journal of rheumatology, 1998, Volume: 37, Issue:11

    Topics: Anti-Arrhythmia Agents; Antiphospholipid Syndrome; Arrhythmias, Cardiac; Foot Diseases; Gangrene; Hu

1998